Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1970 Sep 1;132(3):535–545. doi: 10.1084/jem.132.3.535

SUPPRESSION OF CELL-MEDIATED IMMUNITY TO INFECTION BY AN ANTIMITOTIC DRUG

FURTHER EVIDENCE THAT MIGRANT MACROPHAGES EXPRESS IMMUNITY

R J North 1
PMCID: PMC2138807  PMID: 5523967

Abstract

The development of acquired cell-mediated immunity to infection with Listeria monocytogenes can be blocked by a 15 hr pulse of the antimitotic drug, vinblastine (Vb). The drug has no effect on the host-parasite relationship after 72 hr of infection when a high level of immunity is being expressed, i.e., when infective foci are populated by activated macrophages. Infective foci in mice treated early during infection with Vb do not acquire migrant macrophages, but they become acellular after 48 hr of infection. The results indicate that Vb destroys the dividing precursors of migrant macrophages. The possibility that Vb prevents the activation of these cells by destroying dividing lymphoid cells engaged in the specific immunological phase of the host response is also considered.

Full Text

The Full Text of this article is available as a PDF (772.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen M. G., Schooley J. C. Effects of ionizing radiation and vinblastine on the proliferation of peritoneal macrophage precursors in the mouse. Radiat Res. 1970 Mar;41(3):623–636. [PubMed] [Google Scholar]
  2. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. North R. J. Cellular kinetics associated with the development of acquired cellular resistance. J Exp Med. 1969 Aug 1;130(2):299–314. doi: 10.1084/jem.130.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. North R. J. The mitotic potential of fixed phagocytes in the liver as revealed during the development of cellular immunity. J Exp Med. 1969 Aug 1;130(2):315–326. doi: 10.1084/jem.130.2.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. North R. J. The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J Exp Med. 1970 Sep 1;132(3):521–534. doi: 10.1084/jem.132.3.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. PALMER C. G., LIVENGOOD D., WARREN A. K., SIMPSON P. J., JOHNSON I. S. The action of the vincaleukolastine on mitosis in vitro. Exp Cell Res. 1960 Jun;20:198–201. doi: 10.1016/0014-4827(60)90234-2. [DOI] [PubMed] [Google Scholar]
  7. VOLKMAN A., GOWANS J. L. THE ORIGIN OF MACROPHAGES FROM BONE MARROW IN THE RAT. Br J Exp Pathol. 1965 Feb;46:62–70. [PMC free article] [PubMed] [Google Scholar]
  8. Valeriote F. A., Bruce W. R. An in vitro assay for growth-inhibiting activity of vinblastine. J Natl Cancer Inst. 1965 Nov;35(5):851–856. [PubMed] [Google Scholar]
  9. van Furth R., Cohn Z. A. The origin and kinetics of mononuclear phagocytes. J Exp Med. 1968 Sep 1;128(3):415–435. doi: 10.1084/jem.128.3.415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES